OS Therapies Incorporated
OSTX · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $63 | $47 | $33 | $530 |
| - Cash | $1,877 | $3 | $3 | $6 |
| + Debt | $0 | $0 | $0 | $6 |
| Enterprise Value | -$1,814 | $44 | $30 | $530 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$7 | -$4 | -$4 | -$3 |
| % Margin | – | – | – | – |
| Net Income | -$7 | -$5 | -$4 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.21 | -0.18 | -0.18 | -0.04 |
| % Growth | -16.7% | 0% | -348.9% | – |
| Operating Cash Flow | -$5 | -$2 | -$3 | -$2 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$5 | -$3 | -$4 | -$2 |